≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Biological medicines for asthma

PheWeb

RX_ASTMA_BIOL

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC R03DX05|R03DX08|R03DX09|R03DX10|D11AH05

56

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

46

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

46

diagram downward connector

Include endpoints None

46

diagram downward connector
RX_ASTMA_BIOL

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 46 32 14
Unadjusted prevalence (%) 0.01 0.02 0.01
Mean age at first event (years) 49.62 49.83 49.15

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_ASTMA_BIOL – Biological medicines for asthma
GWS hits:

Survival analyses between endpoints

↥

Plot

before Biological medicines for asthma
after Biological medicines for asthma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Biological medicines for asthma

↥